CY1839A - Process for converting the lower melting polymorphic crystalline form of buspirone hydrochloride into the higher melting form thereof - Google Patents

Process for converting the lower melting polymorphic crystalline form of buspirone hydrochloride into the higher melting form thereof

Info

Publication number
CY1839A
CY1839A CY183995A CY183995A CY1839A CY 1839 A CY1839 A CY 1839A CY 183995 A CY183995 A CY 183995A CY 183995 A CY183995 A CY 183995A CY 1839 A CY1839 A CY 1839A
Authority
CY
Cyprus
Prior art keywords
converting
polymorphic crystalline
crystalline form
melting
buspirone hydrochloride
Prior art date
Application number
CY183995A
Other languages
English (en)
Inventor
Robert J Behme
Terry T Kensler
Douglas G Mikolasek
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1839A publication Critical patent/CY1839A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Gears, Cams (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Arrangement Or Mounting Of Propulsion Units For Vehicles (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Body Structure For Vehicles (AREA)
CY183995A 1987-08-28 1995-12-01 Process for converting the lower melting polymorphic crystalline form of buspirone hydrochloride into the higher melting form thereof CY1839A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/090,302 US4810789A (en) 1987-08-28 1987-08-28 Process for buspirone hydrochloride polymorphic crystalline form conversion

Publications (1)

Publication Number Publication Date
CY1839A true CY1839A (en) 1995-12-01

Family

ID=22222189

Family Applications (1)

Application Number Title Priority Date Filing Date
CY183995A CY1839A (en) 1987-08-28 1995-12-01 Process for converting the lower melting polymorphic crystalline form of buspirone hydrochloride into the higher melting form thereof

Country Status (23)

Country Link
US (1) US4810789A (no)
EP (1) EP0304940B1 (no)
JP (1) JP2702519B2 (no)
KR (1) KR970011294B1 (no)
AT (1) ATE113044T1 (no)
AU (1) AU618746B2 (no)
CY (1) CY1839A (no)
DE (1) DE3851865T2 (no)
DK (1) DK478688A (no)
ES (1) ES2060632T3 (no)
FI (1) FI91066C (no)
HK (1) HK71495A (no)
HU (1) HU199831B (no)
IE (1) IE65988B1 (no)
IL (1) IL87292A (no)
MY (1) MY100863A (no)
NO (1) NO169284C (no)
NZ (1) NZ225895A (no)
OA (1) OA08907A (no)
PT (1) PT88355B (no)
SU (1) SU1731056A3 (no)
YU (1) YU46961B (no)
ZA (1) ZA885867B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
HU217129B (hu) * 1993-07-16 1999-11-29 EGIS Gyógyszergyár Rt. Eljárás nagy tisztaságú buspiron gyógyászati hatóanyag előállítására
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
KR100322018B1 (ko) * 1999-01-23 2002-02-04 윤종용 음성대역 잡음 보상장치
US6465255B1 (en) * 1999-01-29 2002-10-15 The Regents Of The University Of California Method for identifying and probing phase transitions in materials
DE60216641T2 (de) * 2002-04-19 2007-09-27 Faes Farma S.A. Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4351939A (en) * 1980-10-16 1982-09-28 Mead Johnson & Company Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
DD263531A5 (de) * 1986-10-21 1989-01-04 ������@���Kk�� Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
US5015646A (en) * 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone

Also Published As

Publication number Publication date
ATE113044T1 (de) 1994-11-15
ES2060632T3 (es) 1994-12-01
PT88355B (pt) 1995-12-29
NO883806L (no) 1989-03-01
FI883960A0 (fi) 1988-08-26
NO169284B (no) 1992-02-24
FI883960A (fi) 1989-03-01
FI91066C (fi) 1994-05-10
HUT47563A (en) 1989-03-28
IL87292A (en) 1992-07-15
SU1731056A3 (ru) 1992-04-30
DK478688A (da) 1989-03-01
YU46961B (sh) 1994-09-09
AU2048088A (en) 1989-03-02
PT88355A (pt) 1989-06-30
US4810789A (en) 1989-03-07
NO883806D0 (no) 1988-08-25
FI91066B (fi) 1994-01-31
KR970011294B1 (ko) 1997-07-09
NZ225895A (en) 1991-04-26
DK478688D0 (da) 1988-08-26
DE3851865T2 (de) 1995-02-23
JP2702519B2 (ja) 1998-01-21
JPS6471872A (en) 1989-03-16
YU160488A (en) 1990-04-30
AU618746B2 (en) 1992-01-09
HK71495A (en) 1995-05-19
HU199831B (en) 1990-03-28
ZA885867B (en) 1989-05-30
MY100863A (en) 1991-03-15
KR890003739A (ko) 1989-04-17
IE65988B1 (en) 1995-11-29
OA08907A (en) 1989-10-31
IE882362L (en) 1989-02-28
EP0304940B1 (en) 1994-10-19
IL87292A0 (en) 1989-01-31
EP0304940A1 (en) 1989-03-01
NO169284C (no) 1992-06-03
DE3851865D1 (de) 1994-11-24

Similar Documents

Publication Publication Date Title
YU8787A (en) Process for producing substituted pyridinsulphonamde compound
YU201085A (en) Process for obtaining of 2-(2[-substituted-benzoil)-1,3 cyclohexandione
PL271722A1 (en) Method of obtaining novel 2',3'-didesoxynucleosides
HK71495A (en) Process for converting the lower melting polymorphic crystalline form of buspirone hydrochloride into the higher melting form thereof
GR3019973T3 (en) Preparation of substituted tetrahydropyridines
HUT48571A (en) Process for production of substituated 3,5-dichlor-2,4-difluor-benzol
EP0312040A3 (en) 2,4-disubstituted derivatives of tetrahydrofuran
IL97581A0 (en) Process for preparation of fluoromethyl-substituted piperidine carbodithioates
FR2615507B1 (fr) Procede de fabrication d'un compost
YU45030B (en) Process for preparing crystalline cimetidine
EP0264924A3 (en) Process for augmenting the yield of 2,5,6-trimethylcyclohexen-2-one-1
PL265928A2 (en) Method of obtaining novel compound of 2,2,3,4,4-pentamethyl-1,3-oxazolydine
GR3005494T3 (no)
HUT48280A (en) Process for production of starch-2,3,/dihydroxi-prophile/-ether
FR2592873A1 (fr) Nouveau derive monophosphazene, procede d'obtention et application
IE840725L (en) Fine crystalline form of 1, 2, - benzothiazine - 1, 1-¹dioxide
BG43773A1 (en) Method for cleaning of 2, 6- dihydroxyacetophenon with technical grade purity
PT85275A (en) Process for preparing substituted 1,2,3-thiadiazole-4-thiolates
PL261317A1 (en) Procedure for the production of bearings' greases
HU895461D0 (en) Process for the preparation of 2-(2,6-dimethyl-phenyl-amino)-4h-5,6-dihydro-1,3-thiazine
HUT44473A (en) Process for production of 1,2-dietoxi-benzol
HRP931008B1 (en) Process for the preparation of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine